Encephalitis
51
6
9
29
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
11 trials with published results (22%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.9%
2 terminated out of 51 trials
93.5%
+7.0% vs benchmark
18%
9 trials in Phase 3/4
38%
11 of 29 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 29 completed trials
Clinical Trials (51)
Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syndrome and Cerebrospinal Fluid Parameters: a Diagnostic Stewardship Proposal.
CoMind Early Feasibility Study
Clinicolaboratory Predictors of Outcome in Children With Encephalitis
Effects of Combined Music Therapy and Occupational Therapy on Motor and Physiological Parameters in Children With Neurological Impairments: A Non-Randomized Controlled Trial
A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine
Evolving Diagnostic Approaches to Undocumented Lymphocytic Meningitis and Meningoencephalitis
Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)
BIGlobal Intervention Study: Improving Diagnosis and Management of Suspected Brain Infections Globally
Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients
Neuropsychological Rehabilitation Over the Internet
Fosfomycin I.v. for Treatment of Severely Infected Patients
Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis
Central Nervous System Infections in Denmark
Epidemiology and Prognosis of Encephalitis in Intensive Care
Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis
Improving Diagnosis and Prediction of Outcome in Patients With Severe Disorders of Consciousness
The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia
Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab